모바일 주 메뉴 닫기
    Research Consortia
    Research Team (PI)
    Soo bong Han Director of Infectious Diseases Therapeutic Research Center
    Korea Research Institute of Chemical Technology (KRICT) / Chemistry
    Research Labs and Institutes
    A major field of research
    • Discovery and development of antiviral drugs
    • Protein structure-based small molecule drug design
    • Drug optimization through synthetic medicinal chemistry
    • Research on enhancing safety and pharmacological activity
    • Research on bioactive small molecules
    Education
    • Ph.D. in Chemistry, University of Texas at Austin, Dec. 2010
    Career
    • Commissioner, National Bio Committee Dec. 2024 ~ Present
    • Director of Industry-Academia Collaboration, Korean Chemical Society Steering Committee Jan. 2024 ~ Present
    • Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology May 2023 ~ Present
    Achievements
    • Career Experience - 14 years of experience in antiviral drug development and medicinal chemistry research
    • Publications - international journals such as J. Med. Chem., Angew. Chem. Int. Ed., J. Am. Chem. Soc., and Antiviral Research
    • Patents - 41 patents in the field of infectious diseases and therapeutics, with 6 technologies transferred, including antiviral agents (rhinovirus, HBV, picornavirus, oronavirus), vaccine adjuvants, and anticancer agents